Literature DB >> 26382001

High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.

Xuewei Zhu1, Le Sun2, Yusheng Wang2.   

Abstract

CONCLUSION: The current study confirmed the significant high mobility group box 1 (HMGB1) was promoted in human nasopharyngeal carcinoma (NPC) tissues by Epstein-Barr virus (EBV) infection, in association with the malignant status of NPC, and promoted the proliferation NPC cells RAGE-dependently.
OBJECTIVES: The present study was to examine the association of HMGB1 over-expression in human NPC with the EBV-positivity and to determine the regulatory role of HMGB1 on the proliferation of NPC cells in vitro.
METHODS: Real-time PCR and Western blotting were utilized to examine the HMGB1 expression. EBV infection in CNE-2 cells was performed to investigate the HMGB1 promotion by EBV infection. RNA interference technology was utilized for the RAGE knockout.
RESULTS: It was demonstrated that HMGB1 was significantly higher in both mRNA and protein levels in the EBV-positive NPC tissues, in marked association with the malignant status of NPC, and with the LMP1 DNA level in EBV-positive NPC samples. In addition, the MTT assay, growth curve, and the colony forming assay confirmed the promotion by HMGB1 to the proliferation of CNE-2 cells, depending on RAGE.

Entities:  

Keywords:  Epstein-Barr virus (EBV); high mobility group box 1 (HMGB1); nasopharyngeal carcinoma (NPC); proliferation; receptor for advanced glycation end products (RAGE)

Mesh:

Substances:

Year:  2015        PMID: 26382001     DOI: 10.3109/00016489.2015.1082192

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  6 in total

1.  ResolvinD1 attenuates high-mobility group box 1-induced epithelial-to-mesenchymal transition in nasopharyngeal carcinoma cells.

Authors:  Pingli Yang; Shan Chen; Gang Zhong; Yan Wang; Weijia Kong; Yanjun Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-01

2.  Time-dependent risks of cancer clustering among couples: a nationwide population-based cohort study in Taiwan.

Authors:  Jong-Yi Wang; Yia-Wen Liang; Chun-Chen Yeh; Chiu-Shong Liu; Chen-Yu Wang
Journal:  BMJ Open       Date:  2018-02-21       Impact factor: 2.692

3.  Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma.

Authors:  Xuewei Zhu; Jianan Cong; Zhang Lin; Jing Sun; Ben Yang; Aipeng Li
Journal:  Onco Targets Ther       Date:  2020-05-14       Impact factor: 4.147

4.  circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis.

Authors:  Yali Yu; Guixiang Dong; Zijun Li; Yan Zheng; Zhisong Shi; Guanghui Wang
Journal:  Int J Oncol       Date:  2022-02-25       Impact factor: 5.650

5.  HMGB1 Knockout Decreases Kaposi's Sarcoma-Associated Herpesvirus Virion Production in iSLK BAC16 Cells by Attenuating Viral Gene Expression.

Authors:  Su-Kyung Kang; Yun Hee Kang; Seung-Min Yoo; Changhoon Park; Hong Seok Kim; Myung-Shin Lee
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

6.  CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth.

Authors:  Haifeng Huo; Guohua Hu
Journal:  Infect Agent Cancer       Date:  2019-10-30       Impact factor: 2.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.